SILVER SPRING MdA member of a panel advising the government on the safety of a medical device that can spread cancer in women stepped down after the US Food and Drug Administration reviewed consulting fees he accepted from a device manufacturer the agency said Thursday San Francisco gynecologist Andrew Brill removed himself from the member panel before two days of hearings on the device were set to begin Thursday an FDA spokeswoman said A spokesman for Dr Brill referred questions to the FDA 